News tagged with genzyme
Genzyme
Genzyme Corporation (NASDAQ: GENZ) is a fully owned subsidiary of Sanofi-Aventis. Before its acquisition, Genzyme was an American biotechnology company based in Cambridge, Massachusetts. In 2010, Genzyme was the world’s third-largest biotechnology company, employing more than 11,000 people around the world. As a subsidiary of Sanofi-Aventis, Genzyme has a presence in approximately 40 countries, including 17 manufacturing facilities and 9 genetic-testing laboratories, its products are sold in 90 countries. In 2007, Genzyme generated $3.8 billion in revenues with more than 25 products in the market. In 2006 and 2007 Genzyme was named one of Fortune Magazine’s “100 Best Companies to Work for”. The company donated $83 million worth of products worldwide; in 2006, it made $11 million in cash donations. In 2005, Genzyme was awarded the National Medal of Technology, the highest level of honor awarded by the president of the United States to America’s leading innovators.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
LDL cholesterol is a poor marker of heart health in patients with kidney disease
LDL cholesterol is not a useful marker of heart disease risk in patients with kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The finding sugges ...
Diseases, Conditions, Syndromes
May 16, 2013 |
5 / 5 (1) |
0
Sanofi earnings slashed in first quarter
(AP)—French drug maker Sanofi said Thursday its net profit was slashed in the first quarter from a year earlier as falling sales and patent losses on key drugs combined to hammer earnings.
Other
May 02, 2013 |
not rated yet |
0
Drug delivery strategy eliminates myotonia symptoms in mice with myotonic dystrophy
By targeting the specific mutation that causes the hereditary neuromuscular disease myotonic dystrophy, it is possible to neutralize the mutant RNA toxicity and minimize or even eliminate the disabling symptoms ...
Diseases, Conditions, Syndromes
Feb 22, 2013 |
5 / 5 (1) |
0
Drug OK'd for deadly genetic condition tied to cholesterol
(HealthDay)—Kynamro (mipomersen sodium) has been approved by the U.S. Food and Drug Administration to treat a rare inherited condition in which the body can't remove low-density lipoprotein (LDL) cholesterol from the blood.
Medications
Jan 30, 2013 |
not rated yet |
0
Expensive arthritis treatment no better than steroid therapy
A randomized, double-blind clinical trial by researchers at Hospital for Special Surgery has revealed that corticosteroids are more effective than the more expensive treatment, hylan G-F 20 (Synvisc One, ...
Arthritis & Rheumatism
Nov 11, 2012 |
not rated yet |
0
New MS drug proves effective where others have failed
A drug which 'reboots' a person's immune system has been shown to be an effective treatment for multiple sclerosis (MS) patients who have already failed to respond to the first drug with which they were treated (a 'first-line' ...
Neuroscience
Oct 31, 2012 |
5 / 5 (1) |
0
A step forward toward muscular dystrophy treatment: 'Antisense' compound rids muscle cells of toxic RNA
Scientists have reversed symptoms of myotonic muscular dystrophy in mice by eliminating a buildup of toxic RNA in muscle cells. The work, carried out by scientists at the University of Rochester Medical Center, Isis Pharmaceuticals ...
Medical research
Aug 01, 2012 |
4 / 5 (2) |
0
|
